English
This article is from Islets , volume 4 . Abstract Type 1 Diabetes is characterized by an absolute insulin deficiency due to the autoimmune destruction of insulin producing β-cells in the pancreatic islets. Akt1/Protein Kinase B is the direct downstream target of PI3 Kinase activation, and has shown potent anti-apoptotic and proliferation-inducing activities. This study was designed to explore whether gene transfer of constitutively active Akt1 (CA-Akt1) would promote β-cell survival and proliferation, thus be protective against experimental diabetes. In the study, a fiber-modified infectivity-enhanced adenoviral vector, Ad5RGDpK7, was used to deliver rat insulin promoter (RIP)-driven CA-Akt1 into β-cells. Our data showed this vector efficiently delivered CA-Akt1 into freshly isolated pancreatic islets, and promoted islet cell survival and β-cell proliferation in vitro. The therapeutic effect of the vector in vivo was assessed using streptozotocin (STZ)-induced diabetes mice. Two means of vector administration were explored: intravenous and intra-bile ductal injections. While direct vector administration into pancreas via bile-ductal injection resulted in local adverse effect, intra
Sign in with your free account to read, download EPUBs or listen.
Ebook · Gene transfer of active Akt1 by an infectivity-enhanced adenovirus impacts ?-cell survival and proliferation differentially in vitro and in vivo. · Bone, Robert N., Icyuz, Mert, Zhang, Yanqing, Zhang, Yuan, Cui, Wanxing, Wang, Hongjun, Peng, Ji-Bin, Matthews, Qiana L. · Internet Archive